Here are a few key takeaways from our earnings announcement: news.bostonscientific.com/interested-i...

Boston Scientific announces results for Q3 2025: news.bostonscientific.com/2025-10-22-B...

Here are a few key takeaways from our earnings announcement: news.bostonscientific.com/interested-i...

Boston Scientific announces results for Q2 2025: news.bostonscientific.com/2025-07-23-B...

This morning, we announced our Q1 2025 earnings. Here are a few key takeaways: news.bostonscientific.com/interested-i...

In honor of #MinorityHealthMonth, watch Senior Vice President & Global Chief Medical Officer Kenneth Stein speak from the New York Stock Exchange about Close the Gap, our 20+ year effort to reduce barriers to therapies that can make a difference. 🤝 @nycrhythmdoc.bsky.social #Medsky

We have successfully closed the acquisition of Bolt Medical. We look forward to advancing the intravascular lithotripsy (IVL) therapy developed by Bolt which will complement our cardiovascular portfolio by expanding treatment options for coronary and peripheral disease. $BSX

Check out a few key takeaways from our most recent earnings announcement: news.bostonscientific.com/interested-i...